FR2397839A1 - Compose donnant un vaccin oral intestinal - Google Patents
Compose donnant un vaccin oral intestinalInfo
- Publication number
- FR2397839A1 FR2397839A1 FR7721946A FR7721946A FR2397839A1 FR 2397839 A1 FR2397839 A1 FR 2397839A1 FR 7721946 A FR7721946 A FR 7721946A FR 7721946 A FR7721946 A FR 7721946A FR 2397839 A1 FR2397839 A1 FR 2397839A1
- Authority
- FR
- France
- Prior art keywords
- killed
- treating
- attenuated
- comprises specified
- gastroenteritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0266—Klebsiella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Vaccin oral intestinal. Il contient, en plus des différents germes tués ou atténués suivants : Escherichia coli 0111 B4, E. coli 055 B5, E. coli 026 B6, E. coli 086 B7, E. coli 0127 B8, E. coli 0128 B12, E. coli 0129 B14, E. coli 0125 B15, E. coli 0126 B16, E. coli 0124 B17, E. coli 018, aerobacter aerogenes, aerobacter cloacae, klebisiella pneumoniae, proteus OX 19, pseudomonas aeruginosa, streptococcus faecalis et staphylococcus aureus; des produits destinés à améliorer la flore intestinale, à jouer un rôle dans la synthèse des anticorps locaux. Le médicament destiné à prévenir et à traiter les entéro-gastrites contient des germes tués et/ou atténués, de la méthionine, du gluconate de fer et peut contenir aussi des germes non pathogènes vivants et des vitamines.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7721946A FR2397839A1 (fr) | 1977-07-18 | 1977-07-18 | Compose donnant un vaccin oral intestinal |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7721946A FR2397839A1 (fr) | 1977-07-18 | 1977-07-18 | Compose donnant un vaccin oral intestinal |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2397839A1 true FR2397839A1 (fr) | 1979-02-16 |
FR2397839B1 FR2397839B1 (fr) | 1981-07-03 |
Family
ID=9193447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7721946A Granted FR2397839A1 (fr) | 1977-07-18 | 1977-07-18 | Compose donnant un vaccin oral intestinal |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2397839A1 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4606919A (en) * | 1984-08-31 | 1986-08-19 | Solco Basel Ag | Vaccine for the treatment of urinary tract infections containing aluminum phosphate |
WO1996007426A1 (fr) * | 1994-09-06 | 1996-03-14 | Auspharm International Limited | Vaccin contre des infections vaginales s'administrant par voie enterique |
US5538727A (en) * | 1982-06-03 | 1996-07-23 | Dcv Biologics, L.P. | Anti-cholesterolemic vaccine |
US5853765A (en) * | 1982-06-03 | 1998-12-29 | Dcv, Inc. | Anti-cholesterolemic egg, vaccine and method for production, and use |
US6180100B1 (en) * | 1994-09-30 | 2001-01-30 | Urex Biotech., Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
EP1303300A1 (fr) * | 2000-06-19 | 2003-04-23 | Candivax Pty Ltd. | Compositions et procedes de traitement de la candidiase |
-
1977
- 1977-07-18 FR FR7721946A patent/FR2397839A1/fr active Granted
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5538727A (en) * | 1982-06-03 | 1996-07-23 | Dcv Biologics, L.P. | Anti-cholesterolemic vaccine |
US5853765A (en) * | 1982-06-03 | 1998-12-29 | Dcv, Inc. | Anti-cholesterolemic egg, vaccine and method for production, and use |
US5932250A (en) * | 1982-06-03 | 1999-08-03 | Dcv, Inc. | Anti-cholesterolemic egg, vaccine and method for production, and use |
US4606919A (en) * | 1984-08-31 | 1986-08-19 | Solco Basel Ag | Vaccine for the treatment of urinary tract infections containing aluminum phosphate |
WO1996007426A1 (fr) * | 1994-09-06 | 1996-03-14 | Auspharm International Limited | Vaccin contre des infections vaginales s'administrant par voie enterique |
US6180100B1 (en) * | 1994-09-30 | 2001-01-30 | Urex Biotech., Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
EP1303300A1 (fr) * | 2000-06-19 | 2003-04-23 | Candivax Pty Ltd. | Compositions et procedes de traitement de la candidiase |
EP1303300A4 (fr) * | 2000-06-19 | 2004-03-24 | Candivax Pty Ltd | Compositions et procedes de traitement de la candidiase |
Also Published As
Publication number | Publication date |
---|---|
FR2397839B1 (fr) | 1981-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001045679A3 (fr) | Utilisation d'agents chimiotherapeutiques | |
CA2414576A1 (fr) | Renforcement de la sante globale du corps | |
AU2295895A (en) | Dosage forms and method for ameliorating male erectile dysfunction | |
EP0077734A3 (fr) | Production d'anticorps monoclonaux contre des adhésines bactériennes | |
AU2118488A (en) | Improvements in or relating to methods of treating damaged skin | |
AU2001271545A1 (en) | Promoting whole body health | |
HU910177D0 (en) | Process for the production of medical preparations for peroral entering of phimobendane | |
MY109143A (en) | Sulfonamido-and sulfonamidocarbonylpyridine 2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals | |
BG103474A (en) | Application of derivatives of 7-(2-oxa-5,8-diazobicyclo[4,3,0]non-8-8-yl)-quinoloncarboxylic acid and naphthyridoncarboxylic acid in the therapy of helicobacter pylor infections and the gastroduodenal diseases related to them | |
PT97785A (pt) | Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina | |
FR2397839A1 (fr) | Compose donnant un vaccin oral intestinal | |
RU99107569A (ru) | Фармацевтические композиции, обладающие антимикробной активностью | |
SE9201930D0 (sv) | Gastric antibacterial treatment | |
DE3583562D1 (de) | Vakzine zur behandlung der harnwegsinfektionen. | |
NZ510153A (en) | Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals | |
ATE178792T1 (de) | Orale verwendung von calciumformiat zur behandlung von calciumdefizienz bei tieren | |
MX170929B (es) | Empleo de substancias antigenicas para la profilaxis o la terapia de transtornos y enfermedades en el conducto digestivo de animales y humanos | |
ES2136206T3 (es) | Composicion antibacteriana que contiene alfalactalbumina multimerica. | |
EP1038524A4 (fr) | L-threonate ferreux, composition pharmaceutique le contenant et son utilisation pour reduire et traiter l'anemie chez l'homme | |
EP0057323A3 (fr) | Composition anticariogène | |
ATE137967T1 (de) | Verwendung von ketorolac zur behandlung von periodontitis | |
IE32044B1 (en) | Process for the manufacture of a tetanus-vaccine | |
CA2103707A1 (fr) | Traitement des carcinomes pulmonaires autres que le cancer pulmonaire a petites cellules | |
WO1990013660A3 (fr) | Anticorps monoclonaux humains de determinants sero-specifiques de bacteries gram-negatives | |
JPS5577890A (en) | Preparation of alcohol-resistant high-purity phycocyanin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
TP | Transmission of property | ||
ST | Notification of lapse | ||
ST | Notification of lapse | ||
ST | Notification of lapse |